Skip to main content
. 2022 Jun 8;13:910217. doi: 10.3389/fphar.2022.910217

FIGURE 5.

FIGURE 5

THSWD treatment inhibits the generationthe of ROS, activation of NLRP3 inflammasome and secretion of pro-inflammatory cytokine. (A) Quantification of ROS levels; n = 6 per group. (BI) The Western blot relative band density of NLRP3, ASC, cleaved-caspase-1, IL-1β, IL-18; n = 6 per group. Each experiment was repeated 3 times. ** p < 0.01, *** p < 0.001 versus sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 versus MCAO/R group, & p < 0.05, && p < 0.01,&&& p < 0.001 versus MCAO/R + THWSD group.